Last reviewed · How we verify
Dihuang Baoyuan Granules — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Dihuang Baoyuan Granules (Dihuang Baoyuan Granules) — Beijing Supreme Life Pharmaceutical Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dihuang Baoyuan Granules TARGET | Dihuang Baoyuan Granules | Beijing Supreme Life Pharmaceutical Technology Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dihuang Baoyuan Granules CI watch — RSS
- Dihuang Baoyuan Granules CI watch — Atom
- Dihuang Baoyuan Granules CI watch — JSON
- Dihuang Baoyuan Granules alone — RSS
Cite this brief
Drug Landscape (2026). Dihuang Baoyuan Granules — Competitive Intelligence Brief. https://druglandscape.com/ci/dihuang-baoyuan-granules. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab